Guidance on the development and validation of diagnostic tests that depend on nucleic acid amplification and detection

Nick Saunders, Maria Zambon, Ian Sharp, Ruhi Siddiqui, Alison Bermingham, Joanna Ellis, Barry Vipond, Andrew Sails, Jacob Moran-Gilad, Peter Marsh, Malcolm Guiver

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

In order to comply with national and international clinical laboratory accreditation standards (e.g. the ISO 15189, Clinical Pathology Accreditation standards) and with the joint code of practice for research, there must be a method of assessing that test methods are " fit for purpose" . This document gives guidance on development and describes how a validation file is produced. A test method may be a commercial kit, an in-house assay or reagent or a set of reagents bought separately and used to prepare an in house assay.A validation file is needed for both current and new test procedures. The file may refer to data recorded in workbooks, papers and reports. Modifications to assays (including commercially available assays) necessitate either an update to the validation file or creation of a new file.This paper is intended to provide a generic framework for in-house assay development and validation of new nucleic acid amplification assays including real-time polymerase chain reaction (PCR).

Original languageEnglish
Pages (from-to)344-354
Number of pages11
JournalJournal of Clinical Virology
Volume56
Issue number3
DOIs
StatePublished - 1 Jan 2013
Externally publishedYes

Keywords

  • Development
  • Diagnostics
  • Guidance
  • PCR
  • Validation
  • Verification

Fingerprint

Dive into the research topics of 'Guidance on the development and validation of diagnostic tests that depend on nucleic acid amplification and detection'. Together they form a unique fingerprint.

Cite this